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1. INTRODUCTION {#mgg3675-sec-0005}
===============

Asthma is a common chronic pulmonary disease. The clinical features are recurrent wheezing, shortness of breath, chest tightness, cough, and variable expiratory airflow limitation. Symptoms are often aggravated at night and in the morning. In 2016, 339 million people worldwide were suffering from asthma (Collaborators, [2017](#mgg3675-bib-0007){ref-type="ref"}). Asthma is caused by complex environmental and genetic interactions (Ober & Vercelli, [2011](#mgg3675-bib-0022){ref-type="ref"}). Exposure to allergens, tobacco smoke, air pollution, occupational risk factors, viral and bacterial infections, obesity, hygiene, stress, and toxic exposures may be a trigger for asthma (Toskala & Kennedy, [2015](#mgg3675-bib-0032){ref-type="ref"}). Studies on twins suggest that genetic factors involve asthma (Koppelman, Los, & Postma, [1999](#mgg3675-bib-0014){ref-type="ref"}; Laitinen, Rasanen, Kaprio, Koskenvuo, & Laitinen, [1998](#mgg3675-bib-0016){ref-type="ref"}). Genome‐wide association studies of asthma have confirmed that the locus polymorphism of over 500 genes was involved in the pathogenesis of asthma (Macarthur et al., [2017](#mgg3675-bib-0018){ref-type="ref"}).

Various T cell subtypes (Th1, Th2, Th9, Th17, NK, ILC2, and T regulatory cells) involved in asthma pathogenesis (Holgate et al., [2015](#mgg3675-bib-0010){ref-type="ref"}). Nucleotide‐binding oligomerization domain‐containing protein 2 is a protein that is encoded by the *NOD2* (OMIM 605956) gene located on chromosome 16 in humans and spans a 39 kb genomic region comprised of 17 exons. *NOD2*‐deficient mice increased Toll‐like receptor 2--mediated T helper type 1 responses (Watanabe, Kitani, Murray, & Strober, [2004](#mgg3675-bib-0035){ref-type="ref"}). Nucleotide binding and oligomerization domain 2 is an intracellular protein that recognizes bacterial muramyl dipeptide (Tigno‐Aranjuez & Abbott, [2012](#mgg3675-bib-0031){ref-type="ref"}). This bacterial sensor NOD2 can trigger a strong antigen specific immune response with a Th2‐type polarization profile (Magalhaes et al., [2008](#mgg3675-bib-0019){ref-type="ref"}). Moreover, NOD2 as a viral pattern recognition receptor that can sense viral to activate IFN‐β production and antiviral defense (Sabbah et al., [2009](#mgg3675-bib-0026){ref-type="ref"}). The expression of interferon‐β in bronchial epithelial cells of asthma is impaired to infection with rhinovirus (Wark et al., [2005](#mgg3675-bib-0034){ref-type="ref"}). NOD2 plays an important role in inflammatory and immune responses (Carneiro, Magalhaes, Tattoli, Philpott, & Travassos, [2008](#mgg3675-bib-0006){ref-type="ref"}). *NOD2* has been involved in the development of Crohn\'s disease, early onset sarcoidosis, Blau syndrome, autoimmune disease, allergy, and asthma (Ni, Chen, Wu, Zhu, & Song, [2017](#mgg3675-bib-0021){ref-type="ref"}).

Previous studies have found that *NOD2* polymorphism is associated with asthma in the German population (Kabesch et al., [2003](#mgg3675-bib-0013){ref-type="ref"}; Weidinger et al., [2005](#mgg3675-bib-0036){ref-type="ref"}). However, until now, the current studies failed to provide a basis for the genetic correlation of *NOD2* variations and asthma in the Chinese populations. Therefore, the aim of this research was to identify the role of *NOD2* polymorphisms in the genetic basis of asthma in the Chinese population and to evaluate the relationship between the *NOD2* polymorphisms and the serum level of interferon‐β.

2. MATERIALS AND METHODS {#mgg3675-sec-0006}
========================

2.1. Ethical compliance {#mgg3675-sec-0007}
-----------------------

This research was conducted in accordance with the ethical standards of the Declaration of Helsinki. The research has been approved by the Ethics Committee of the Yancheng Third People\'s Hospital. Informed written consent was obtained from all parents.

2.2. Study subjects {#mgg3675-sec-0008}
-------------------

The case‐control study included 163 controls and 309 asthmatic children. The asthmatic children in this study were in the clinical remission stage. Children were diagnosed for asthma according to the following criteria: cough, wheezing, shortness of breath, chest tightness, and lung function test. Controls were children without a history of allergy and family history of asthma. The controls underwent a routine medical checkup in the Medical Examination Center, Yancheng Third People\'s Hospital, Yancheng, China, between January 2016 and December 2017. All study subjects were of the Chinese Han population and resided in Yancheng, China.

2.3. DNA extraction and genotyping {#mgg3675-sec-0009}
----------------------------------

Genomic DNA was extracted using the TIANamp Blood DNA Kit (Tiangen BiotechCo., Ltd., Beijing, China) following the manufacturers' instructions and then stored at −80°C. SNP in the human *NOD2* (GenBank: AF178930.1) genes with minor allele frequencies \>10% were selected from the HapMap Chinese data set. Tag SNPs were then selected by a tagger, using Haploview 4.2 software. The designs of PCR primers were carried out by online primer 3.0 software (<http://primer3.ut.ee/>). The SNaPshot was used to analyze genotypes of SNPs.

2.4. Serum IFN‐β determination {#mgg3675-sec-0010}
------------------------------

The quantity determination of serum IFN‐β levels was performed by IFN‐β Human ELISA Kit (Invitrogen) following the manufacturer\'s instructions.

2.5. Statistical analysis {#mgg3675-sec-0011}
-------------------------

For comparison of values between cases and controls, Student\'s *t* tests and the *χ* ^2^‐test were used. The Hardy--Weinberg equilibrium was tested for using *χ* ^2^‐test goodness of fit. Odds ratios (ORs) and 95% confidence intervals (CIs) were used for assessing the allele on the risk of asthma. The SPSS 17.0 was used for statistical analyses, and statistical significance was assumed at the *p* \< 0.05 level. The statistical power to detect association of the polymorphisms with *NOD2* was 0.80 and was estimated with PASS 11 software (<https://www.ncss.com>).

3. RESULTS {#mgg3675-sec-0012}
==========

3.1. Clinical characteristics of the study participants {#mgg3675-sec-0013}
-------------------------------------------------------

There were no significant differences in the age and gender between patients and controls (*p* \> 0.05) (Table [1](#mgg3675-tbl-0001){ref-type="table"}). Asthma patients showed a significantly high rate of household smoking and recurrent respiratory infection (*p* \< 0.05). Total IgE concentration in serum of the children with asthma was significantly higher than the controls (*p* \< 0.05). Compared with the control group, the serum IFN‐β levels were significantly lower in the group of patients with asthma \[(50.2 ± 15.6 pg/ml, *n* = 309) vs. (70.2 ± 14.7 pg/ml, *n* = 163); *t* = 13.483, *p* = 0.000\].

###### 

Clinical characteristics of the participants

  Variable                          Asthma patients   Control subjects   *p*
  --------------------------------- ----------------- ------------------ -------
  Age (mean ± *SD*)                 10.7 ± 2.1        11.2 ± 2.6         0.409
  Gender (M/F)                      187/122           94/69              0.549
  sIgE (IU/ml)                      302.8 ± 87.5      61.3 ± 38.2        0.000
  Household smoking                 91                30                 0.009
  Recurrent respiratory infection   106               22                 0.000
  Atopy                             216               0                  --
  Severity                          45                0                  --
  Rhinitis                          147               0                  --
  Medication                        254               0                  --
  FEV~1~/FVC (%)                    78.2 ± 6.4        --                 --
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3.2. The genotype and allele frequencies of NOD2 gene polymorphisms {#mgg3675-sec-0014}
-------------------------------------------------------------------

Thirty‐four SNPs of *NOD2*, with minor allele frequencies \>10%, were identified in the HapMap Chinese data set (Table [2](#mgg3675-tbl-0002){ref-type="table"}), and all were captured by 4 tag SNPs of *NOD2*, using a tagger in Haploview software. For *NOD2*, pairwise tagging was performed at *r* ^2^ \> 0.8, and the mean *r* ^2^ was 0.974. Next, genotyping was performed using the 4 tag SNPs. In the cases and the controls, the genotype distributions of rs1077861, rs3135499, rs1861759, and rs2111234 were consistent with the Hardy--Weinberg equilibrium (all *p* \> 0.05).

###### 

Tag and captured SNPs in the NOD2 gene

  Tag SNPs        rs1077861    rs3135499    rs1861759     rs2111234
  --------------- ------------ ------------ ------------- -----------
  Captured SNPs   rs11642646   rs13332952   rs113656815   rs2111235
  rs17312836      rs9925315    rs79877183                 
  rs11642482      rs3135500    rs1861757                  
  rs11647841      rs8057341    rs61199363                 
  rs8045009       rs4785449    rs79984321                 
  rs34133110      rs4785225                               
  rs10521209      rs7187857                               
  rs748855        rs751271                                
  rs8061960       rs9921146                               
  rs7203691       rs6500328                               
  rs2357791       rs8057341                               
  rs1861758                                               
  rs4990643                                               
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The distribution of genotypes and alleles frequencies of the 4 tag SNPs in the group of cases and the group of controls are shown in Table [3](#mgg3675-tbl-0003){ref-type="table"}. Under codominant and dominant models, the genotype frequencies of the *NOD2* rs3135499 polymorphisms were statistically significant between the patients and the controls (*p* \< 0.05). The rs3135499 C allele was associated with a significantly increased risk of asthma as compared with the rs3135499 A allele (OR = 1.762, 95% CI, 1.220--2.545, *p* = 0.002). However, the rs1077861, rs1861759, and rs2111234 SNPs were not significantly associated with asthma pathogenesis (*p* \> 0.05).

###### 

The distribution of genotype frequencies of NOD2 polymorphisms in asthma children and controls

  SNPs        Model              Asthma                 Control   OR (95%CI)   *p*
  ----------- ------------ ----- ---------------------- --------- ------------ -------
  rs1077861   Codominant   TT    198                    115       1            0.297
  AT          102          43    1.378 (0.902--2.105)                          
  AA          9            5     1.045 (0.342--3.195)                          
  Dominant    TT           198   115                    1         0.157        
  AT+AA       111          48    1.343 (0.892--2.022)                          
  Recessive   AA           9     5                      1         0.925        
  TT+AT       300          158   1.055 (0.348--3.201)                          
  Allele      T            498   273                    1         0.233        
  A           120          53    0.806 (0.565--1.149)                          
  rs3135499   Codominant   AA    183                    122       1            0.003
  AC          116          37    2.090 (1.353--3.230)                          
  CC          10           4     1.667 (0.511--5.435)                          
  Dominant    AA           183   122                    1         0.001        
  AC+CC       126          41    2.049 (1.346--3.119)                          
  Recessive   CC           10    4                      1         0.634        
  AA+AC       299          159   0.752 (0.232--2.437)                          
  Allele      A            482   281                    1         0.002        
  C           136          45    1.762 (1.220--2.545)                          
  rs1861759   Codominant   AA    209                    112       1            0.840
  AC          85           45    1.012 (0.660--1.553)                          
  CC          15           6     1.340 (0.506--3.549)                          
  Dominant    AA           209   112                    1         0.812        
  AC+CC       100          51    1.051 (0.699--1.580)                          
  Recessive   CC           15    6                      1         0.557        
  AA+AC       294          157   0.749 (0.285--1.969)                          
  Allele      A            503   269                    1         0.671        
  C           115          57    0.927 (0.653--1.316)                          
  rs2111234   Codominant   CC    129                    77        1            0.247
  CT          146          75    1.162 (0.782--1.727)                          
  TT          34           11    1.845 (0.884--3.852)                          
  Dominant    CC           129   77                     1         0.253        
  CT+TT       180          86    1.249 (0.853--1.830)                          
  Recessive   TT           34    11                     1         0.135        
  CC+CT       275          152   0.585 (0.288--1.188)                          
  Allele      C            404   229                    1         0.130        
  T           214          97    0.800 (0.599--1.068)                          
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3.3. Distribution of IFN‐β between cases and controls {#mgg3675-sec-0015}
-----------------------------------------------------

*NOD2* gene polymorphisms and clinical parameters had been further investigated for the impact of serum IFN‐β levels (Tables [4](#mgg3675-tbl-0004){ref-type="table"} and [5](#mgg3675-tbl-0005){ref-type="table"}). We further found that severe asthma patients had lower levels of IFN‐β than nonsevere asthma. But, we failed to find any association of the rs1077861, rs3135499, rs1861759, and rs2111234 with serum level of IFN‐β.

###### 

Distribution of IFN‐β between cases and controls

  Model                      Asthma        Control                 
  ------------ ------------- ------------- --------- ------------- -------
  Codominant   AA            50.7 ± 16.6   0.734     71.1 ± 14.2   0.334
  AC           49.6 ± 12.8   68.0 ± 16.4                           
  CC           47.8 ± 25.5   63.0 ± 10.8                           
  Dominant     AA            50.7 ± 16.6   0.463     71.1 ± 14.2   0.182
  AC+CC        49.4 ± 14.1   67.5 ± 15.9                           
  Recessive    CC            47.8 ± 25.5   0.772     63.0 ± 10.8   0.327
  AA+AC        50.3 ± 15.2   70.4 ± 14.8                           
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###### 

The distribution of NOD2 genotype and IFN‐β protein in different clinical characteristics

  Group                             Variable   Genotype   *p*   IFN‐β levels (pg/ml)   *p*                   
  --------------------------------- ---------- ---------- ----- ---------------------- ------------- ------- --
  Asthma                                                                                                     
  Household smoking                                                                                          
  Positive                          57         31         3     0.715                  50.7 ± 16.0   0.687   
  Negative                          126        85         7                            50.0 ± 15.5           
  Recurrent respiratory infection                                                                            
  Positive                          65         37         4     0.755                  50.6 ± 15.3   0.736   
  Negative                          118        79         6                            50.0 ± 15.8           
  Atopy                                                                                                      
  Positive                          122        86         8     0.304                  50.8 ± 15.8   0.31    
  Negative                          61         30         2                            48.8 ± 15.3           
  Severity                                                                                                   
  Positive                          25         18         2     0.802                  39.5 ± 16.1   0.000   
  Negative                          158        98         8                            52.0 ± 14.8           
  Rhinitis                                                                                                   
  Positive                          90         53         4     0.747                  50.2 ± 15.3   0.979   
  Negative                          93         63         6                            50.2 ± 16.0           
  Medication                                                                                                 
  Positive                          152        93         9     0.659                  50.0 ± 16.1   0.698   
  Negative                          31         23         1                            50.9 ± 13.4           
  Control                                                                                                    
  Household smoking                                                                                          
  Positive                          21         8          1     0.784                  70.3 ± 16.9   0.964   
  Negative                          101        29         3                            70.1 ± 14.2           
  Recurrent respiratory infection                                                                            
  Positive                          16         6          0     0.646                  70.1 ± 16.7   0.986   
  Negative                          106        31         4                            70.2 ± 14.4           
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4. DISCUSSION {#mgg3675-sec-0016}
=============

Asthma is a common chronic respiratory disease in the world. Environmental and genetic factors affect the development of asthma. Environmental exposure to tobacco smoke is the most important risk factor for asthma, and causes airway inflammation (Sheikh, Pitts, Ryan‐Wenger, Mccoy, & Hayes, [2016](#mgg3675-bib-0028){ref-type="ref"}). As a potential innate immune mechanism, the nucleotide‐binding oligomerization domain‐like receptors (NLRs) based inflammasome can increase the response to pollutants (Bauer, Diaz‐Sanchez, & Jaspers, [2012](#mgg3675-bib-0003){ref-type="ref"}). As intracellular sensors, NLRs include 22 members in humans and 34 members in mice (Motta, Soares, Sun, & Philpott, [2015](#mgg3675-bib-0020){ref-type="ref"}). NOD2 belongs to the NLR family and functions as a general sensor for both Gram‐positive and Gram‐negative bacteria by identifying muramyl dipeptide (Kufer, Banks, & Philpott, [2006](#mgg3675-bib-0015){ref-type="ref"}). It was found that the physiological role of *NOD2* in antiviral defense was the enhanced respiratory syncytial virus pathogenesis, lung disease, and greater viral susceptibility through the study of *NOD2*‐deficient mice (Sabbah et al., [2009](#mgg3675-bib-0026){ref-type="ref"}). NOD2 participates in host responses to infectious pathogens, including bacteria, viruses, and parasites (Al Nabhani, Dietrich, Hugot, & Barreau, [2017](#mgg3675-bib-0002){ref-type="ref"}).

Genetic polymorphisms may be related to the development of diseases (Huang, [2015](#mgg3675-bib-0011){ref-type="ref"}). There are some SNPs of *NOD2* that have been identified as susceptibility loci of Crohn\'s disease, including 1007 fs, G908R, P268S, and R702W (Cao et al., [2018](#mgg3675-bib-0005){ref-type="ref"}). A research reported that the *NOD2* gene rs2066842 and rs2066843 polymorphisms showed a significant association with ulcerative colitis, but not with Crohn\'s in Indian patients (Pugazhendhi, Santhanam, Venkataraman, Creveaux, & Ramakrishna, [2013](#mgg3675-bib-0024){ref-type="ref"}). Ahangari, Salehi, Salehi, & Khanahmad ([2014](#mgg3675-bib-0001){ref-type="ref"}) showed that the rs3135500 AA genotype had a significant association with risk of Colorectal cancer in the Iran population. The research data of Cao et al. suggest that the rs3135500 variant might increase the risk for multiple system atrophy. A previous study found that the rs751271 polymorphism was associated with inflammatory reactions in leprosy (Sales‐Marques et al., [2017](#mgg3675-bib-0027){ref-type="ref"}). Weidinger et al., ([2005](#mgg3675-bib-0036){ref-type="ref"}) study found that the rs1077861 T allele decreased the risk of asthma, whereas the rs3135500 A allele was significantly associated with an increased risk of asthma.

Nod1 (Nucleotide‐binding oligomerization domain‐containing protein 1, encoded by the *NOD1* gene) and *NOD2* are important recognition receptors involved in inflammation and immune response(Elia, Tolentino, Bernardazzi, & de Souza, [2015](#mgg3675-bib-0009){ref-type="ref"}). NOD1 and NOD2 conferred a upregulation of NF‐κB transactivation in transfected cells(Rosenstiel et al., [2006](#mgg3675-bib-0025){ref-type="ref"}). *NOD1* insertion/deletion polymorphism was correlated with and inflammatory bowel disease in Caucasian populations(Lu, [2010](#mgg3675-bib-0017){ref-type="ref"}). Previous research reported that *NOD1 *+* *32656 polymorphism is associated with elevated serum IgE levels(Hysi et al., [2005](#mgg3675-bib-0012){ref-type="ref"}). The *NOD1 *+* *32656 locus insertion allele exhibit a significantly elevated production of IL‐1β and IL‐6(Plantinga et al., [2013](#mgg3675-bib-0023){ref-type="ref"}). Three locus polymorphisms within the coding region of *NOD2*, G908R, R702W, and L1007fsinsC display a deficit in NF‐kB activation in response to bacterial components(Bonen et al., [2003](#mgg3675-bib-0004){ref-type="ref"}; Rosenstiel et al., [2006](#mgg3675-bib-0025){ref-type="ref"}). R702W, G908R, and Leu1007fsinsC polymorphisms in the *NOD2* gene were reported to be associated with sepsis susceptibility(Tekin et al., [2012](#mgg3675-bib-0030){ref-type="ref"}). A study found that the *NOD2* rs3135499 polymorphism is associated with enhanced production of IL‐17A in human toxoplasmosis(Dutra et al., [2012](#mgg3675-bib-0008){ref-type="ref"}). Therefore, it might be possible that mutations in *NOD1* or *NOD2* gene influence directly or indirectly to change in levels of inflammatory factors that may lead to an abnormal immune response.

In this study, we have analyzed the potential associations of polymorphisms in the *NOD2* gene with asthma in Chinese population. Among 4 tag SNPs of *NOD2* that were identified using tagger in Haploview software. The rs3135499 polymorphisms in the *NOD2* gene was significantly associated with asthma in the Chinese Han population. Furthermore, the rs3135499 C allele increased the risk of asthma as compared with the rs3135499 A allele. In addition, previous studies had found that rs3135499 polymorphisms involved in retinochoroiditis and leprosy(Dutra et al., [2012](#mgg3675-bib-0008){ref-type="ref"}; Xiong et al., [2016](#mgg3675-bib-0037){ref-type="ref"}). And the serum level of IFN‐β was significantly reduced in the cases as compared with the controls in this study. However, the distribution of the serum IFN‐β levels of individuals with AA, AC, and CC genotypes were no differences in the asthma group or the controls. These results suggested that rs3135499 polymorphisms may not affect the expression of serum IFN‐β. Previous studies had found IFN‐β expression was deficient in asthmatic patients (Sykes et al., [2012](#mgg3675-bib-0029){ref-type="ref"}; Uller et al., [2010](#mgg3675-bib-0033){ref-type="ref"}). A statistical significance was observed in the distribution of IFN‐β levels between severe asthma and nonsevere asthma patients. The result indicated that low levels of IFN‐β may be contribute to the susceptibility to severe asthma.

In summary, this study provided evidence that the *NOD2* gene rs3135499 polymorphism genotypes differed between children with asthma and healthy children in the Chinese Han population. The rs3135499 C allele as a risk factor may influence the development of asthma. Nonetheless, due to the limited sample size and the specific genetic characteristics of the Chinese population, the pathogenesis of *NOD2* in asthma needs further study to verify our results.

CONFLICT OF INTEREST {#mgg3675-sec-0018}
====================

All authors report no conflict of interest relevant to this article.

We acknowledge the children with asthma, volunteers, and their families for their collaboration.
